In a new opinion piece, infectious disease specialists Krutika Kuppalli and Placide Mbala argue that recent Ebola and Marburg virus outbreaks expose a fundamental weakness in global health defenses. They contend that the world remains too reliant on tests designed for specific pathogens, a strategy that leaves gaps when new or unexpected viruses emerge.
The authors, drawing from their experience in the Bundibugyo region, say that diagnostic systems need to be able to identify a broad range of pathogens without prior knowledge of the infectious agent. This approach, they argue, could accelerate outbreak response and reduce the time between detection and containment.
Kuppalli and Mbala write that “what is urgently needed is a shift from pathogen-specific diagnostics toward pathogen-agnostic diagnostic systems.” They emphasize that current testing frameworks often fail during the critical early days of an outbreak when the pathogen is still unknown.
The implications are significant for global health policy and funding priorities. Shifting to agnostic platforms would require substantial investment in technology and training, but could fundamentally alter how quickly the world responds to the next pandemic.
Some experts caution that pathogen-agnostic systems remain technically challenging and expensive, potentially diverting resources from proven surveillance methods. The debate reflects a broader tension between innovation and practicality in pandemic preparedness.